Wednesday, June 10, 2026

pharma Β· Breast Cancer Β· Prostate Cancer Β· UTHR

United Therapeutics Europe

United Therapeutics Europe clinical programs β€” 1032 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

1000 Spring Street, Silver Spring, Maryland 20910, US HQ
1996 Founded
1,443 Employees
Public company Type
UTHR Β· NYSE Ticker
Company details
Status
Public
HQ
1000 Spring Street, Silver Spring, Maryland 20910, US
Founded
1996
Employees
1,443
Programs
1032
Drugs
612
Patents
3720
Intelligence Β· Clinical Programs

United Therapeutics Europe projects

1,032 ClinicalTrials.gov programs sponsored by United Therapeutics Europe.

United Therapeutics Europe has 1,032 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

Page 9 of 22
  1. Nasal Carbon Dioxide

    United Therapeutics Europe Ltd

    Migraine

    phase 2 small molecule terminated

    1 trial
  2. Nivolumab

    United Therapeutics Europe Ltd

    Metastatic Uveal Melanoma

    phase 2 small molecule completed

    1 trial
  3. Non-invasive ventilation

    United Therapeutics Europe Ltd

    Amyotrophic Lateral Sclerosis (ALS)

    phase 2 other active

    1 trial
  4. OGX-011

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 2 mab completed

    1 trial
  5. Octreotide Acetate

    United Therapeutics Europe Ltd

    Liver Transplantation

    phase 2 small molecule active

    1 trial
  6. Olaparib

    United Therapeutics Europe Ltd

    Bile Duct Adenocarcinoma

    phase 2 small molecule active

    1 trial
  7. Oral treprostinil

    United Therapeutics Europe Ltd

    Systemic Sclerosis

    phase 2 small molecule completed

    1 trial
  8. Oral versus topical antibioitics

    United Therapeutics Europe Ltd

    Chronic Rhinosinusitis (Diagnosis)

    phase 2 small molecule terminated

    1 trial
  9. Oxytocin

    United Therapeutics Europe Ltd

    Alcohol Use Disorder

    phase 2 small molecule completed

    1 trial
  10. PT150

    United Therapeutics Europe Ltd

    PTSD - Post Traumatic Stress Disorder

    phase 2 small molecule active

    1 trial
  11. PUL-042 Inhalation Solution

    United Therapeutics Europe Ltd

    COVID-19

    phase 2 small molecule completed

    2 trials
  12. Paclitaxel

    United Therapeutics Europe Ltd

    Clinical Stage III Gastric Cancer AJCC v8

    phase 2 small molecule active

    1 trial
  13. Palbociclib 125Mg Tab

    United Therapeutics Europe Ltd

    ER+ Breast Cancer

    phase 2 small molecule active

    1 trial
  14. Palmidrol

    United Therapeutics Europe Ltd

    Chemotherapy-Induced Peripheral Neuropathy

    phase 2 small molecule active

    1 trial
  15. Panitumumab

    United Therapeutics Europe Ltd

    Metastatic Colon Adenocarcinoma

    phase 2 mab active

    1 trial
  16. Parenteral Remodulin (treprostinil) injection

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    phase 2 small molecule terminated

    1 trial
  17. Pembrolizumab

    United Therapeutics Europe Ltd

    Triple Negative Breast Cancer

    phase 2 small molecule active

    1 trial
  18. Pembrolizumab

    United Therapeutics Europe Ltd

    Pancreatic Cancer

    phase 2 small molecule active

    1 trial
  19. Pembrolizumab

    United Therapeutics Europe Ltd

    Metastatic Small Intestinal Adenocarcinoma

    phase 2 mab active

    1 trial
  20. Pembrolizumab

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 2 small molecule active

    1 trial
  21. Pembrolizumab

    United Therapeutics Europe Ltd

    Castration-resistant Prostate Cancer

    phase 2 small molecule active

    1 trial
  22. Pembrolizumab (200mg IV for 30 minutes

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 2 small molecule active

    1 trial
  23. Pirfenidone

    United Therapeutics Europe Ltd

    Cardiac Failure

    phase 2 small molecule completed

    1 trial
  24. Placebo

    United Therapeutics Europe Ltd

    Influenza

    phase 2 small molecule completed

    1 trial
  25. Placebo Infusion

    United Therapeutics Europe Ltd

    Brain Injuries, Traumatic

    phase 2 mab active

    1 trial
  26. Placebo oral capsule

    United Therapeutics Europe Ltd

    Osteoarthritis, Knee

    phase 2 small molecule completed

    1 trial
  27. Population Council #323

    United Therapeutics Europe Ltd

    Contraception

    phase 2 small molecule completed

    1 trial
  28. ProSpare

    United Therapeutics Europe Ltd

    Cancer

    phase 2 other active

    1 trial
  29. Prostate alone IMRT

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 2 other active

    1 trial
  30. Psilocybin (Usona Institute)

    United Therapeutics Europe Ltd

    Spinal Cord Injury

    phase 2 small molecule active

    1 trial
  31. Pulmonary Rehabilitation (PR)

    United Therapeutics Europe Ltd

    Non-small Cell Lung Cancer Stage III

    phase 2 other active

    1 trial
  32. Qutenza

    United Therapeutics Europe Ltd

    Pulmonary Hypertension

    phase 2 small molecule completed

    1 trial
  33. Qutenza (8% capsaicin)

    United Therapeutics Europe Ltd

    Pulmonary Hypertension

    phase 2 small molecule completed

    1 trial
  34. Radiation: 131I-MIBG

    United Therapeutics Europe Ltd

    Neuroblastoma

    phase 2 small molecule active

    1 trial
  35. Ralinepag

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    phase 2 small molecule completed

    1 trial
  36. Recombinant human growth hormone

    United Therapeutics Europe Ltd

    Gulf War Syndrome

    phase 2 small molecule active

    1 trial
  37. Regorafenib

    United Therapeutics Europe Ltd

    Adenocarcinoma of the Gastroesophageal Junction

    phase 2 small molecule terminated

    1 trial
  38. Riboflavin

    United Therapeutics Europe Ltd

    Keratolysis

    phase 2 small molecule completed

    1 trial
  39. Rituximab

    United Therapeutics Europe Ltd

    Fatigue

    phase 2 mab completed

    1 trial
  40. Roginolisib

    United Therapeutics Europe Ltd

    Leukemia

    phase 2 small molecule active

    1 trial
  41. Ropivacaine injection

    United Therapeutics Europe Ltd

    Stress Disorders, Post-Traumatic

    phase 2 small molecule active

    2 trials
  42. Rucaparib

    United Therapeutics Europe Ltd

    Cervical Cancer

    phase 2 small molecule terminated

    1 trial
  43. S-1

    United Therapeutics Europe Ltd

    Advanced Non-Small Cell Lung Cancer

    phase 2 small molecule completed

    2 trials
  44. S-1

    United Therapeutics Europe Ltd

    Locally Advanced or Metastatic Pancreatic Cancer

    phase 2 small molecule completed

    1 trial
  45. SARS-CoV-2 convalescent plasma

    United Therapeutics Europe Ltd

    SARS-CoV 2

    phase 2 mab completed

    1 trial
  46. SPINALON (buspirone + levodopa + cardidopa)

    United Therapeutics Europe Ltd

    Spinal Cord Injury

    phase 2 small molecule completed

    1 trial
  47. SRX246

    United Therapeutics Europe Ltd

    PTSD

    phase 2 small molecule terminated

    1 trial
  48. SX-682

    United Therapeutics Europe Ltd

    Metastatic Castrate-Resistant Prostate Cancer (mCRPC)

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does United Therapeutics Europe have?

1,032 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.